0001181431-12-039521.txt : 20120703
0001181431-12-039521.hdr.sgml : 20120703
20120703172806
ACCESSION NUMBER: 0001181431-12-039521
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120629
FILED AS OF DATE: 20120703
DATE AS OF CHANGE: 20120703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bailey Gregory
CENTRAL INDEX KEY: 0001329505
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32836
FILM NUMBER: 12946223
MAIL ADDRESS:
STREET 1: 4 A CHESHAM STREET
CITY: LONDON
STATE: X0
ZIP: SW1X8DT
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDIVATION, INC.
CENTRAL INDEX KEY: 0001011835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133863260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-543-3470
MAIL ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: ORION ACQUISITION CORP II
DATE OF NAME CHANGE: 19960408
4
1
rrd349998.xml
6/29/12 -- SALES
X0306
4
2012-06-29
0
0001011835
MEDIVATION, INC.
MDVN
0001329505
Bailey Gregory
C/O MEDIVATION, INC.
525 MARKET ST., 36TH FLOOR
SAN FRANCISCO
CA
94105
1
0
0
0
Common Stock
2012-06-29
4
S
0
1500
88.67
D
345821
D
Common Stock
2012-06-29
4
S
0
6500
89.72
D
339321
D
Common Stock
2012-06-29
4
S
0
2000
90.40
D
337321
D
Common Stock
2012-06-29
4
S
0
1000
91.54
D
336321
D
Common Stock
2012-07-02
4
S
0
5500
93.40
D
330821
D
Common Stock
2012-07-03
4
S
0
2000
95.17
D
328821
D
The shares were sold at prices ranging from $88.64 to $88.765. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $89.20 to $90.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $93.05 to $93.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $95.05 to $95.28. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ C. Patrick Machado, Attorney-in-fact
2012-07-03